- Backblaze issued $201.25 million in 0 % convertible senior notes due 2031 through a private placement and executed related capped call transactions to mitigate equity dilution.
- The company also amended its credit agreement to upsize its revolving credit facility to $50 million, extend its maturity to April 30, 2030, and adjust covenants.
- These financial actions are intended to bolster liquidity, extend the operational runway, and manage potential conversion dilution.
- Bank of America increased its stake in Gerdau to 5.07% on Aug. 20, 2026, reaching a total holding of 63,970,174 preferred shares.
- The transaction triggered a CVM 5% disclosure requirement, alongside a cash-settled derivative exposure of 223,569 shares representing 0.02% of outstanding shares.
- Bank of America stated that the acquisition does not aim to seek changes in the company's control or management.
- Bank of America crossed above the 10% voting-rights threshold in Lakefront Biotherapeutics on Aug. 18, 2026, through share purchases and financial instruments.
- As of Aug. 19, 2026, the bank held 6,662,597 total voting rights, representing 10.11% of the 65,897,071 outstanding shares.
- This total holding comprised 1,419,144 direct voting rights at 2.15% and 5,243,453 equivalent financial instruments at 7.96%.
- Citigroup lowered its price objective for DouYu International from $ 5.20 to $ 5.00 while maintaining a neutral rating on the stock.
- DouYu International reported first-quarter earnings of $ 0.15 per share on revenue of $ 119.20 million, with institutional investors recently adjusting their holdings.
- The company maintains a market capitalization of $ 128.86 million and a consensus rating of Reduce among analysts.
- Evotec AG stock reached a new 52-week low of $1.89 with recent trading volume at 12,713 shares.
- Multiple equities analysts have adjusted their ratings and price targets, resulting in a consensus rating of "Hold" and an average price target of $3.00.
- Institutional investors and hedge funds currently own 5.81% of the company's stock following recent position adjustments.
- Alibaba recently announced its first share placement since 2019, issuing 710 million new shares at HK$112.7 each to raise capital for AI infrastructure and strengthen its balance sheet.
- Investment banks like Nomura and BofA maintain a positive outlook, noting that the equity dilution of about 3.7% is manageable and that the financing successfully eliminates long-term funding uncertainties.
- Despite initial market volatility and short-term downward technical pressure, analysts emphasize that the capital raise supports long-term growth and preserves a strong net cash position.
- Century Therapeutics has received a consensus recommendation of "Hold" from 7 ratings firms, with an average 12 - month target price of $4.75.
- Institutional investors and hedge funds, including Bank of America and Goldman Sachs, have recently adjusted their holdings in the company, which now has 50.20 % of its stock owned by institutional investors.
- The clinical-stage biotechnology company reported an EPS of -$0.17 for the quarter, missing consensus estimates, and maintains a market capitalization of $382.96 million.
- Bank of America Corporation filed a public opening position and dealing disclosure regarding its interests in the relevant securities of EASYJET PLC under Rule 8.3 of the Takeover Code.
- The disclosure reports total relevant securities owned and controlled of 19,828,862 shares, representing 2.616 %, alongside cash-settled and stock-settled derivative positions.
- Recent market dealings included the purchase of 3,841,751 shares at 6.71 GBP and cash-settled derivative transactions increasing short positions.
- CM Wealth Advisors LLC purchased 12,648 shares of Bank of America Corporation valued at approximately $721,000 during the second quarter.
- Bank of America reported a quarterly earnings per share of $1.21 and revenue of $31.56 billion, surpassing consensus estimates.
- The company announced an increased quarterly dividend of $0.32 per share, scheduled to be paid on Friday, September 25th.
- Csenge Advisory Group purchased 31,896 shares of Bank of America Corporation valued at approximately $1,817,000 during the second quarter.
- Bank of America reported quarterly earnings of $1.21 per share with revenue of $31.56 billion, surpassing analysts' expectations.
- The company announced an increased quarterly dividend of $0.32 per share, payable on September 25, 2026.
- GSA Capital Partners LLP acquired a new stake of 31,541 shares in Verizon Communications Inc. valued at approximately $1,335,000 during the second quarter.
- Several other large institutional investors also modified their holdings in the telecommunications company, contributing to a total institutional ownership of 62.06%.
- Verizon Communications reported a second-quarter EPS of $1.30, beating estimates, alongside recent insider transactions and varied analyst price target updates.
- Bank of America Corp DE increased its holdings in Solaris Resources Inc. by 15.6% during the 1st quarter by purchasing an additional 172,564 shares.
- The institutional investor held 1,276,075 shares valued at $10,949,000, representing approximately 0.76% of the company at the end of the quarter.
- Several other institutional investors, including Goldman Sachs Group Inc. and Amundi, also modified their positions in Solaris Resources during recent periods.
- Bank of America increased its stake in Structure Therapeutics by 617.0% in the first quarter, owning 227,132 shares valued at $10,948,000.
- Several institutional investors and hedge funds also adjusted their positions, with 91.78% of the stock currently owned by institutional investors and hedge funds.
- Structure Therapeutics reported quarterly earnings of ($0.49) per share, while maintaining a consensus rating of Moderate Buy among analysts with an average price target of $110.91.